0%
0%
0%
0%
0%
−18.30USD
−114.527MUSD
About Evelo Biosciences, Inc.
Sector
CEO
Balkrishan Gill
Headquarters
Cambridge
Website
Employees
66
Founded
2014
ISIN
US2997342025
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
When to run away from cup and handle and when to hold? $EVLO$EVLO has completed cup and handle on weekly chart, but it also slid drastically!
Any suggestions in this case?
Stocks To Watch This WeekThe Bull Market is strong. This week I tried to pick the absolute best names that present exceptional reward/risk. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There are 13 total stoc
EVLO: Descending TriangleDescending Triangle
Pros
Descending volume
PPS below 50MA and 200MA
250RSI below 50
200MA descending
ATR descending
R/R ratio above 6
If confirmed:
PT1 = 1,30$
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
